NCT06397378 · Michigan State University
Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
(HPV videos)
What this study is about
HPV vaccines offer hope against HPV-associated cancers for males and females; however, the rate of vaccination has not reached projected public health goals.
View original scientific description
HPV vaccines offer hope against HPV-associated cancers for males and females; however, the rate of vaccination has not reached projected public health goals. This study will engage key stakeholders in the research process to co-design and pilot testing a video-based intervention addressing low HPV vaccination rates among college students The intervention and its approach have the potential to reduce health disparities in HPV-associated cancers in young adults via low-cost technology and timely intervention.
Interventions
OTHER
short videos related to HPV and the HPV vaccine
Eight college students created and developed four videos on human papillomavirus (HPV) and the HPV vaccine, designed to increase their knowledge and attitude, shape subjective norms, enhance perceived behavioral control, and strengthen intentions to receive the HPV vaccine. Two months after the video intervention, we will follow up with participants to collect their self-reported vaccine uptake status. Outcomes will be compared with those of another group whose participants will watch a video presenting CDC information on HPV and the HPV vaccine, adapted into a narrated voiceover format.
OTHER
CDC HPV Fact Sheet
We did not develop this intervention. Instead, we will use information from the CDC website on HPV and the HPV vaccine and convert it into a video with a narrated voiceover format. Because our student advisory board will develop four short videos, participants who are randomly assigned to the CDC fact sheet group will watch the converted CDC video four times to ensure that all groups are exposed to the same number of videos. Here is the CDC link: https://www.cdc.gov/hpv/vaccines/?CDC\_AAref\_Val=https://www.cdc.gov/hpv/parents/vaccinesafety.html
Primary outcome measures
Participants' HPV vaccination intention
Time frame: through study completion, an average of 1 year
The investigators will assess participants' intention to receive HPV vaccines before and after watching HPV vaccine-related videos, t
Participants' HPV vaccine uptake
Time frame: through study completion, an average of 1 year
Participants will be asked if they received any HPV vaccines after watching the videos.
Participants' attitude toward receiving the HPV vaccines
Time frame: through study completion, an average of 1 year
Participants' attitude toward receiving HPV vaccines will be assessed before and after watching videos.
Participants' subjective norms
Time frame: through study completion, an average of 1 year
Participants' subjective norms regarding receiving HPV vaccines will be assessed before and after watching videos.
Participants' perceived behavioral controls
Time frame: through study completion, an average of 1 year
Participants' perceived behavioral control regarding receiving HPV vaccines will be assessed before and after watching videos.
Participants' satisfaction
Time frame: through study completion, an average of 1 year
participants' satisfaction about the interventions.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- college students aged 18-26 never receive HPV vaccines able to understand English.
Exclusion criteria
- not able to understand English younger than 18 or older than 26 years old have received HPV vaccines.
Where
- East Lansing, Michigan
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Sep 25, 2025 · Source of record for eligibility and locations